NCT02730195: Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid Leukemia |
|
|
| Terminated | 2 | 9 | US | Pioglitazone, Actos, Pioglitazone Hydrochloride, Tyrosine Kinase Inhibitor (TKI), Protein Tyrosine Kinase Inhibitors, PTK Inhibitors, TK Inhibitors | Emory University | Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | 07/18 | 07/18 | | |